secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2026-08-12T22:22:46+00:00
Accession:  0001193125-26-347315
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OnKure reprices underwater options to $4.14; ~1.7M shares affected
------------------------------------------------------------------

- Board approved repricing of eligible options with exercise price >= $10.00 to $4.14, effective Aug 7, 2026.
- CEO Saccomano: 571,423 options repriced; CMO Agresta: 149,984; CFO Leverone: 141,714.
- Repriced options total ~1.7M shares; original exercise prices ranged $13.99-$24.59.
- Retention requirement: 18 months for senior management, 1 year for others; no change to term, vesting, or share count.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000119312526347315/0001193125-26-347315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000119312526347315/okur-20260807.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-347315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer